日本无码

Curated 日本无码: NEJM

Filters close
日本无码: Measuring Lung Function More Accurately and More Equitably
16-May-2024 1:30 PM EDT
Measuring Lung Function More Accurately and More Equitably
Harvard Medical School

Race-based assessments of lung function have historically assumed different levels of 鈥渘ormal鈥 for different patient groups. New analysis shows that removing from lung function estimates would increase the number of Black patients diagnosed with serious disease.Greater estimated disease severity would change a patient鈥檚 diagnosis, disability compensation, eligibility for certain jobs.

日本无码: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
14-May-2024 5:00 PM EDT
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
University of Texas MD Anderson Cancer Center

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy 鈥 given before and after surgery 鈥 significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.

Released: 13-May-2024 3:05 PM EDT
Texas Tech Researchers Help Confirm First Case of Avian Influenza Transmitted from Cow to Human
Texas Tech University

Researchers from the Biological Threat Response Laboratory played a critical role in testing for the virus.

13-May-2024 9:30 AM EDT
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy
Lahey Hospital & Medical Center

One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.

Released: 2-May-2024 6:00 AM EDT
Four state-of-the-art, artificial intelligence search engines for histopathology images may not be ready for clinical use
University of California, Los Angeles (UCLA), Health Sciences

Four proposed state-of-the art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care. Some had less than 50% accuracy, which is not suitable for clinical practice.

24-Apr-2024 2:05 PM EDT
Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease
Children's Hospital of Philadelphia

An international consortium published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

23-Apr-2024 7:05 AM EDT
It鈥檚 easier now to treat opioid addiction with medication -- but use has changed little
Michigan Medicine - University of Michigan

In the first year after the sudden removal of a requirement that prescribers get special permission to prescribe medication for opioid addiction, a study finds more prescribers started providing it, but the number of patients receiving it didn't rise very much.

日本无码: UTSW Research: Food allergies, weight-loss surgery, and more
Released: 2-Apr-2024 12:05 PM EDT
UTSW Research: Food allergies, weight-loss surgery, and more
UT Southwestern Medical Center

Roundup of recent research involving UT Southwestern faculty members: Antibody treatment lowers risk for food allergies; Weight-loss surgery support offered for teens; Racial disparities found among pregnant patients with multiple sclerosis; Gestational age increased at start of COVID-19 pandemic

Released: 28-Mar-2024 11:30 AM EDT
Private and Secure Generative AI Tool Supports Operations and Research at Dana-Farber
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or hospital.

Released: 26-Mar-2024 3:05 PM EDT
Flu-Vaccine Education in the Emergency Department Helps People get their Shot
Thomas Jefferson University

Patient education about flu shot during a non-life threatening emergency department visit increases vaccination rates, especially in patients without regular primary care.

Released: 20-Mar-2024 5:05 PM EDT
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence
University of California, Los Angeles (UCLA), Health Sciences

A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a new study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators.

Released: 14-Mar-2024 5:05 PM EDT
UChicago Medicine helps bring first-of-its-kind drug for metabolic liver disease to the clinic
University of Chicago Medical Center

Resmetirom (Rezdiffra) is the first drug approved for treating MASH, an advanced form of fatty liver disease. UChicago Medicine experts contributed to a recent clinical trial and will begin incorporating the drug into liver disease treatment regimens for eligible patients.

日本无码: UCLA Health Taps Dr. Priscilla Hsue as Chief of the Cardiology Division
Released: 14-Mar-2024 2:30 PM EDT
UCLA Health Taps Dr. Priscilla Hsue as Chief of the Cardiology Division
University of California, Los Angeles (UCLA), Health Sciences

The UCLA Department of Medicine is pleased to announce that Priscilla Hsue, MD will be joining us as the chief of the Division of Cardiology at UCLA, effective July 1, 2024.

11-Mar-2024 11:05 AM EDT
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
Fred Hutchinson Cancer Center

A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a study published March 14 in the New England Journal of Medicine.

Released: 7-Mar-2024 11:05 AM EST
Combination Urothelial Cancer Treatment Nearly Doubles Patient Survival in International Trial
Johns Hopkins Medicine

Combining the anticancer drugs enfortumab vedotin and pembrolizumab (EV+P) led to significantly improved survival rates among patients with advanced urothelial cancer (the most common type of bladder cancer) compared with standard chemotherapy, according to results of a large international clinical trial involving 185 sites, including the Johns Hopkins Kimmel Cancer Center鈥檚 Greenberg Bladder Cancer Institute, in 25 countries.

Released: 28-Feb-2024 3:05 PM EST
How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis
University of North Carolina School of Medicine

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)鈥攖he first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

日本无码: Berkowitz Authors NEJM Perspective Piece on Food Insecurity
Released: 26-Feb-2024 2:05 PM EST
Berkowitz Authors NEJM Perspective Piece on Food Insecurity
University of North Carolina Health Care System

Published in the New England Journal of Medicine, Seth A. Berkowitz, MD, MPH, associate professor of medicine at the UNC School of Medicine, wrote perspective piece on how medically tailored meals address health consequences of food insecurity.

Released: 26-Feb-2024 8:05 AM EST
First Drug to Help Reduce Allergic Reactions to Multiple Food Allergies, Tested at Children鈥檚 and Emory, Now FDA Approved
Children's Healthcare of Atlanta

Children鈥檚 Healthcare of Atlanta and Emory University participated in a nationwide clinical trial showing that a 16-week course of omalizumab, an injectable drug, increased the amount of peanut, tree nuts, egg, milk and wheat that some multi-food allergic children as young as one year could consume without an allergic reaction after exposure.

日本无码: Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food Allergies
21-Feb-2024 12:00 PM EST
Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food Allergies
Johns Hopkins Medicine

A study led by Johns Hopkins Children鈥檚 Center shows omalizumab聽鈥斅燼n injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and other allergic conditions聽鈥斅爏ubstantially reduced potentially life-threatening reactions in patients with an allergy to peanut and other common food allergies.

Released: 23-Feb-2024 1:05 PM EST
Researchers identify new choice of therapy for rare autoimmune disease EGPA
McMaster University

An international team, including researchers from McMaster University and St. Joseph鈥檚 Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior to mepolizumab in the treatment of EGPA.

Released: 12-Feb-2024 11:05 AM EST
Antibody drug conjugates make strides in ovarian cancer with recent FDA approval
University of California, Los Angeles (UCLA), Health Sciences

The UCLA team played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate (ADC), mirvetuximab soravtansine, for the treatment of platinum-resistant ovarian cancer.

日本无码: International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
9-Feb-2024 9:05 AM EST
International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
University Hospitals Cleveland Medical Center

In a major, international study, named SELECT2, a University Hospitals (UH) research team found that patients with large strokes had a dramatically better recovery after endovascular thrombectomy plus medical management at long-term follow-up, than patients who only received standard medical management.

Released: 7-Feb-2024 5:10 PM EST
UTHealth Houston report in NEJM: Deadly fungal infection acquired during surgery in Mexico led to death and brainstem, blood supply injuries
University of Texas Health Science Center at Houston

A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according to physicians from UTHealth Houston.

Released: 2-Feb-2024 11:05 AM EST
Gene-editing offers hope for people with hereditary disorder
University of Auckland

A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, according to the lead researcher.

日本无码: Large Multicenter Clinical Trial Finds that Antiseptic Containing Iodine Reduces Surgical-Site Infections in Patients with Extremity Fractures
Released: 1-Feb-2024 7:00 AM EST
Large Multicenter Clinical Trial Finds that Antiseptic Containing Iodine Reduces Surgical-Site Infections in Patients with Extremity Fractures
University of Maryland Medical Center

A large multicenter clinical trial co-led by University of Maryland School of Medicine researchers found that an antiseptic containing iodine resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic.

29-Jan-2024 10:05 AM EST
Surgeons鈥 choice of skin disinfectant impacts infection risk, Canadian-American study shows
McMaster University

Researchers of the PREPARE trial, which enrolled nearly 8,500 participants at 25 hospitals in Canada and the United States, found the use of iodine povacrylex in alcohol to disinfect a patient鈥檚 skin could prevent surgical site infection in thousands of patients undergoing surgery for a closed fracture each year.

17-Jan-2024 5:00 AM EST
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

日本无码: About 22 high school age adolescents died each week from overdoses in 2022, driven by fentanyl-laced prescription pills
5-Jan-2024 5:05 PM EST
About 22 high school age adolescents died each week from overdoses in 2022, driven by fentanyl-laced prescription pills
University of California, Los Angeles (UCLA), Health Sciences

Embargoed research finds an average of 22 adolescents 14 to 18 years of age died in the U.S. each week in 2022 from drug overdoses, raising the death rate for this group to 5.2 per 100,000-- driven by fentanyl in counterfeit pills. The researchers also found 19 "hotspot" counties with particularly high overdose deaths.

Released: 5-Jan-2024 3:05 PM EST
UC Davis Health creates road map to diversify health care workforce
UC Davis Health

In a new case study published in New England Journal of Medicine Catalyst鈥檚 January 2024 issue, UC Davis Health shared a road map for increasing workforce diversity across the health care industry.

Released: 4-Jan-2024 4:05 PM EST
A blood test can identify genetic diseases in fetuses
University of Southern Denmark

A research team from Odense University Hospital and the University of Southern Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus.

日本无码: Gorelick_David.jpg
Released: 19-Dec-2023 4:05 PM EST
UM School of Medicine Review Highlights Rise in Psychiatric Disorders Linked to Increased Cannabis Use
University of Maryland School of Medicine

The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article that was recently published in the New England Journal of Medicine. It highlights the urgent need for doctors to screen for and treat patients who are experiencing symptoms of cannabis use disorder, which means they are experiencing significant problems from their use of the drug.

Released: 7-Dec-2023 5:05 PM EST
World-first trial offers new hope for type 1 diabetes
ST Vincent's Institute Of Medical Research

Researchers at St Vincent’s Institute of Medical Research (SVI) in Melbourne have shown that a commonly prescribed rheumatoid arthritis drug can suppress the progression of type 1 diabetes.鈥  The world-first human trial, published today in the New England Journal of Medicine and led by SVI’s Professor Thomas Kay, showed that a drug called baricitinib can safely and effectively preserve the body’s own insulin production and suppress the progression of type 1 diabetes in people who initiated treatment within 100 days of diagnosis.

日本无码: Long-standing hormone treatment for donated hearts found to be ineffective
28-Nov-2023 2:05 PM EST
Long-standing hormone treatment for donated hearts found to be ineffective
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis and Mid-America Transplant showed that the long-standing practice of treating deceased organ donors with thyroid hormone does not help preserve heart function, may cause harm and should be discontinued.

Released: 16-Nov-2023 12:05 PM EST
Excessive fluid consumption: habit or hormonal disorder?
University of Basel

Researchers found that a test using salt infusion is more reliable than a test using arginine infusion to differentiate between excessive fluid ingestion and vasopressin deficiency.

Not for public release

This news release is embargoed until 12-Nov-2023 8:45 AM EST Released to reporters: 9-Nov-2023 12:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 12-Nov-2023 8:45 AM EST The 日本无码 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

11-Nov-2023 10:10 AM EST
Transfusing More Blood May Benefit Patients Who Have Had Heart Attack and Have Anemia
Rutgers University-New Brunswick

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.

日本无码: NEJM: Study Supports Minimally Invasive Procedure for Aortic Stenosis
Released: 24-Oct-2023 6:05 PM EDT
NEJM: Study Supports Minimally Invasive Procedure for Aortic Stenosis
Cedars-Sinai

Patients with a dysfunctional aortic heart valve who received a new, prosthetic valve through a minimally invasive procedure had similar outcomes at five years as those who underwent open-heart surgery, a new study shows.

日本无码: Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
20-Oct-2023 6:00 PM EDT
Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
University of Texas MD Anderson Cancer Center

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.

日本无码: FDA Approves Minimally Invasive Therapy Shown to Save the Legs of Severe Vascular Disease Patients from Amputation
Released: 12-Sep-2023 3:05 PM EDT
FDA Approves Minimally Invasive Therapy Shown to Save the Legs of Severe Vascular Disease Patients from Amputation
University Hospitals Cleveland Medical Center

The FDA today announced approval of a therapy giving thousands of patients hope for an alternative to amputation of their legs.

29-Aug-2023 5:55 PM EDT
New study shows promising evidence for sickle cell gene therapy
University of Chicago Medical Center

UChicago Medicine Comer Children鈥檚 Hospital was one of three sites to enroll patients in a clinical trial to test a potentially curative stem cell gene therapy for sickle cell disease. The results were promising.

Released: 29-Aug-2023 2:05 PM EDT
Preparing clinicians for the international anti-LGBTQI+ crisis
Boston University School of Medicine

Lesbian, gay, bisexual, transgender, queer, intersex and additional sexual and gender minority (LGBTQI+) people in every region of the world face marginalization and oppression.

日本无码: Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography
Released: 27-Aug-2023 3:40 AM EDT
Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography
Mount Sinai Health System

Results from a large-scale clinical trial could increase usage of high resolution imaging for guiding interventional coronary procedures

Released: 25-Aug-2023 4:05 PM EDT
Weight loss medication benefits patients with heart failure and obesity
European Society of Cardiology

Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

日本无码: Adrenocortical carcinoma: No mitotane for low risk of recurrence
Released: 25-Aug-2023 12:50 PM EDT
Adrenocortical carcinoma: No mitotane for low risk of recurrence
University of W眉rzburg

In 2017, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of Mitotane in the prevention of recurrence in adrenocortical carcinoma.

Not for public release

This news release is embargoed until 16-Aug-2023 5:00 PM EDT Released to reporters: 16-Aug-2023 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Aug-2023 5:00 PM EDT The 日本无码 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
2.08249